カテゴリー： 世界, 医療/バイオ, LP Information

世界の合成抗体市場予測 2023年-2029年

【英語タイトル】Global Synthetic Antibody Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08691）・商品コード：LP23DC08691
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の合成抗体市場」は、過去の販売実績から2022年の世界の合成抗体の総販売量を検討し、2023年から2029年の予測される合成抗体の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の合成抗体の市場規模を掲載し、XXX百万米ドル規模の世界の合成抗体市場の詳細な分析を提供します。本インサイトレポートは、世界の合成抗体業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の合成抗体市場における各社の独自のポジションをより深く理解するために、合成抗体製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の合成抗体市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。合成抗体の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。合成抗体の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。合成抗体のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

合成抗体の世界主要メーカーとしては、Abcam、 Merck、 Cell Signaling Technology、 GE Healthcare、 Thermo Fisher Scientific、 Roche、 Santa Cruz Biotechnology、 Becton Dickinson、 Rockland Immunochemicals、 Johnson & Johnsonなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の合成抗体市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では合成抗体市場をセグメンテーションし、種類別 (組換え抗体、非免疫グロブリン由来合成抗体)、用途別 (がん、中毒、ウイルス感染症、敗血症、自己免疫疾患、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：組換え抗体、非免疫グロブリン由来合成抗体

・用途別区分：がん、中毒、ウイルス感染症、敗血症、自己免疫疾患、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の合成抗体市場の10年間の市場状況・展望は？
・世界および地域別に見た合成抗体市場成長の要因は何か？
・合成抗体の市場機会はエンドマーケットの規模によってどのように変化するのか？
・合成抗体のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：合成抗体の年間販売量2018-2029、地域別現状・将来分析
・合成抗体の種類別セグメント：組換え抗体、非免疫グロブリン由来合成抗体
・合成抗体の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・合成抗体の用途別セグメント：がん、中毒、ウイルス感染症、敗血症、自己免疫疾患、その他
・合成抗体の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の合成抗体市場
・企業別のグローバル合成抗体市場データ：2018-2023年の年間販売量、市場シェア
・企業別の合成抗体の年間売上：2018-2023年の売上、市場シェア
・企業別の合成抗体販売価格
・主要企業の合成抗体生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

合成抗体の地域別レビュー
・地域別の合成抗体市場規模2018-2023：年間販売量、売上
・主要国別の合成抗体市場規模2018-2023：年間販売量、売上
・南北アメリカの合成抗体販売の成長
・アジア太平洋の合成抗体販売の成長
・ヨーロッパの合成抗体販売の成長
・中東・アフリカの合成抗体販売の成長

南北アメリカ市場
・南北アメリカの国別の合成抗体販売量、売上（2018-2023）
・南北アメリカの合成抗体の種類別販売量
・南北アメリカの合成抗体の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の合成抗体販売量、売上（2018-2023）
・アジア太平洋の合成抗体の種類別販売量
・アジア太平洋の合成抗体の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の合成抗体販売量、売上（2018-2023）
・ヨーロッパの合成抗体の種類別販売量
・ヨーロッパの合成抗体の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の合成抗体販売量、売上（2018-2023）
・中東・アフリカの合成抗体の種類別販売量
・中東・アフリカの合成抗体の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・合成抗体の製造コスト構造分析
・合成抗体の製造プロセス分析
・合成抗体の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・合成抗体の主要なグローバル販売業者
・合成抗体の主要なグローバル顧客

地域別の合成抗体市場予測レビュー
・地域別の合成抗体市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・合成抗体の種類別市場規模予測
・合成抗体の用途別市場規模予測

主要企業分析
Abcam、 Merck、 Cell Signaling Technology、 GE Healthcare、 Thermo Fisher Scientific、 Roche、 Santa Cruz Biotechnology、 Becton Dickinson、 Rockland Immunochemicals、 Johnson & Johnson
・企業情報
・合成抗体製品
・合成抗体販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Synthetic Antibody market size is projected to grow from US$ 58020 million in 2022 to US$ 151070 million in 2029; it is expected to grow at a CAGR of 14.6% from 2023 to 2029.
United States market for Synthetic Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Synthetic Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Synthetic Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Synthetic Antibody players cover Abcam, Merck, Cell Signaling Technology, GE Healthcare, Thermo Fisher Scientific, Roche, Santa Cruz Biotechnology, Becton Dickinson and Rockland Immunochemicals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Synthetic antibodies are affinity reagents generated entirely in vitro, thus completely eliminating animals from the production process. Synthetic antibodies include recombinant antibodies, nucleic acid aptamers and non-immunoglobulin protein scaffolds. As a consequence of their in vitro manufacturing method the antigen recognition site of synthetic antibodies can be engineered to any desired target and may extend beyond the typical immune repertoire offered by natural antibodies. Synthetic antibodies are being developed for use in research, diagnostic and therapeutic applications. Synthetic antibodies can be used in all applications where traditional monoclonal or polyclonal antibodies are used and offer many inherent advantages over animal-derived antibodies, including comparatively low production costs, reagent reproducibility and increased affinity, specificity and stability across a range of experimental conditions.
LPI (LP Information)’ newest research report, the “Synthetic Antibody Industry Forecast” looks at past sales and reviews total world Synthetic Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Synthetic Antibody sales for 2023 through 2029. With Synthetic Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Antibody industry.
This Insight Report provides a comprehensive analysis of the global Synthetic Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Synthetic Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Synthetic Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Antibody market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Recombinant Antibodies
Non-Immunoglobulin Derived Synthetic Antibodies
Segmentation by application
Cancer
Poisoning
Viral Infections
Septicemia
Autoimmune Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abcam
Merck
Cell Signaling Technology
GE Healthcare
Thermo Fisher Scientific
Roche
Santa Cruz Biotechnology
Becton Dickinson
Rockland Immunochemicals
Johnson & Johnson
Key Questions Addressed in this Report
What is the 10-year outlook for the global Synthetic Antibody market?
What factors are driving Synthetic Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Synthetic Antibody market opportunities vary by end market size?
How does Synthetic Antibody break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Synthetic Antibody Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Synthetic Antibody by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Synthetic Antibody by Country/Region, 2018, 2022 & 2029
2.2 Synthetic Antibody Segment by Type
2.2.1 Recombinant Antibodies
2.2.2 Non-Immunoglobulin Derived Synthetic Antibodies
2.3 Synthetic Antibody Sales by Type
2.3.1 Global Synthetic Antibody Sales Market Share by Type (2018-2023)
2.3.2 Global Synthetic Antibody Revenue and Market Share by Type (2018-2023)
2.3.3 Global Synthetic Antibody Sale Price by Type (2018-2023)
2.4 Synthetic Antibody Segment by Application
2.4.1 Cancer
2.4.2 Poisoning
2.4.3 Viral Infections
2.4.4 Septicemia
2.4.5 Autoimmune Diseases
2.4.6 Others
2.5 Synthetic Antibody Sales by Application
2.5.1 Global Synthetic Antibody Sale Market Share by Application (2018-2023)
2.5.2 Global Synthetic Antibody Revenue and Market Share by Application (2018-2023)
2.5.3 Global Synthetic Antibody Sale Price by Application (2018-2023)
3 Global Synthetic Antibody by Company
3.1 Global Synthetic Antibody Breakdown Data by Company
3.1.1 Global Synthetic Antibody Annual Sales by Company (2018-2023)
3.1.2 Global Synthetic Antibody Sales Market Share by Company (2018-2023)
3.2 Global Synthetic Antibody Annual Revenue by Company (2018-2023)
3.2.1 Global Synthetic Antibody Revenue by Company (2018-2023)
3.2.2 Global Synthetic Antibody Revenue Market Share by Company (2018-2023)
3.3 Global Synthetic Antibody Sale Price by Company
3.4 Key Manufacturers Synthetic Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Synthetic Antibody Product Location Distribution
3.4.2 Players Synthetic Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Synthetic Antibody by Geographic Region
4.1 World Historic Synthetic Antibody Market Size by Geographic Region (2018-2023)
4.1.1 Global Synthetic Antibody Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Synthetic Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Synthetic Antibody Market Size by Country/Region (2018-2023)
4.2.1 Global Synthetic Antibody Annual Sales by Country/Region (2018-2023)
4.2.2 Global Synthetic Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas Synthetic Antibody Sales Growth
4.4 APAC Synthetic Antibody Sales Growth
4.5 Europe Synthetic Antibody Sales Growth
4.6 Middle East & Africa Synthetic Antibody Sales Growth
5 Americas
5.1 Americas Synthetic Antibody Sales by Country
5.1.1 Americas Synthetic Antibody Sales by Country (2018-2023)
5.1.2 Americas Synthetic Antibody Revenue by Country (2018-2023)
5.2 Americas Synthetic Antibody Sales by Type
5.3 Americas Synthetic Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Synthetic Antibody Sales by Region
6.1.1 APAC Synthetic Antibody Sales by Region (2018-2023)
6.1.2 APAC Synthetic Antibody Revenue by Region (2018-2023)
6.2 APAC Synthetic Antibody Sales by Type
6.3 APAC Synthetic Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Synthetic Antibody by Country
7.1.1 Europe Synthetic Antibody Sales by Country (2018-2023)
7.1.2 Europe Synthetic Antibody Revenue by Country (2018-2023)
7.2 Europe Synthetic Antibody Sales by Type
7.3 Europe Synthetic Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Synthetic Antibody by Country
8.1.1 Middle East & Africa Synthetic Antibody Sales by Country (2018-2023)
8.1.2 Middle East & Africa Synthetic Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa Synthetic Antibody Sales by Type
8.3 Middle East & Africa Synthetic Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Synthetic Antibody
10.3 Manufacturing Process Analysis of Synthetic Antibody
10.4 Industry Chain Structure of Synthetic Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Synthetic Antibody Distributors
11.3 Synthetic Antibody Customer
12 World Forecast Review for Synthetic Antibody by Geographic Region
12.1 Global Synthetic Antibody Market Size Forecast by Region
12.1.1 Global Synthetic Antibody Forecast by Region (2024-2029)
12.1.2 Global Synthetic Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Synthetic Antibody Forecast by Type
12.7 Global Synthetic Antibody Forecast by Application
13 Key Players Analysis
13.1 Abcam
13.1.1 Abcam Company Information
13.1.2 Abcam Synthetic Antibody Product Portfolios and Specifications
13.1.3 Abcam Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abcam Main Business Overview
13.1.5 Abcam Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Synthetic Antibody Product Portfolios and Specifications
13.2.3 Merck Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Cell Signaling Technology
13.3.1 Cell Signaling Technology Company Information
13.3.2 Cell Signaling Technology Synthetic Antibody Product Portfolios and Specifications
13.3.3 Cell Signaling Technology Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cell Signaling Technology Main Business Overview
13.3.5 Cell Signaling Technology Latest Developments
13.4 GE Healthcare
13.4.1 GE Healthcare Company Information
13.4.2 GE Healthcare Synthetic Antibody Product Portfolios and Specifications
13.4.3 GE Healthcare Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GE Healthcare Main Business Overview
13.4.5 GE Healthcare Latest Developments
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Information
13.5.2 Thermo Fisher Scientific Synthetic Antibody Product Portfolios and Specifications
13.5.3 Thermo Fisher Scientific Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Thermo Fisher Scientific Main Business Overview
13.5.5 Thermo Fisher Scientific Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche Synthetic Antibody Product Portfolios and Specifications
13.6.3 Roche Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 Santa Cruz Biotechnology
13.7.1 Santa Cruz Biotechnology Company Information
13.7.2 Santa Cruz Biotechnology Synthetic Antibody Product Portfolios and Specifications
13.7.3 Santa Cruz Biotechnology Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Santa Cruz Biotechnology Main Business Overview
13.7.5 Santa Cruz Biotechnology Latest Developments
13.8 Becton Dickinson
13.8.1 Becton Dickinson Company Information
13.8.2 Becton Dickinson Synthetic Antibody Product Portfolios and Specifications
13.8.3 Becton Dickinson Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Becton Dickinson Main Business Overview
13.8.5 Becton Dickinson Latest Developments
13.9 Rockland Immunochemicals
13.9.1 Rockland Immunochemicals Company Information
13.9.2 Rockland Immunochemicals Synthetic Antibody Product Portfolios and Specifications
13.9.3 Rockland Immunochemicals Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Rockland Immunochemicals Main Business Overview
13.9.5 Rockland Immunochemicals Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson Synthetic Antibody Product Portfolios and Specifications
13.10.3 Johnson & Johnson Synthetic Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Synthetic Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Synthetic Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Recombinant Antibodies
Table 4. Major Players of Non-Immunoglobulin Derived Synthetic Antibodies
Table 5. Global Synthetic Antibody Sales by Type (2018-2023) & (Units)
Table 6. Global Synthetic Antibody Sales Market Share by Type (2018-2023)
Table 7. Global Synthetic Antibody Revenue by Type (2018-2023) & ($ million)
Table 8. Global Synthetic Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global Synthetic Antibody Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Synthetic Antibody Sales by Application (2018-2023) & (Units)
Table 11. Global Synthetic Antibody Sales Market Share by Application (2018-2023)
Table 12. Global Synthetic Antibody Revenue by Application (2018-2023)
Table 13. Global Synthetic Antibody Revenue Market Share by Application (2018-2023)
Table 14. Global Synthetic Antibody Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Synthetic Antibody Sales by Company (2018-2023) & (Units)
Table 16. Global Synthetic Antibody Sales Market Share by Company (2018-2023)
Table 17. Global Synthetic Antibody Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Synthetic Antibody Revenue Market Share by Company (2018-2023)
Table 19. Global Synthetic Antibody Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Synthetic Antibody Producing Area Distribution and Sales Area
Table 21. Players Synthetic Antibody Products Offered
Table 22. Synthetic Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Synthetic Antibody Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Synthetic Antibody Sales Market Share Geographic Region (2018-2023)
Table 27. Global Synthetic Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Synthetic Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Synthetic Antibody Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Synthetic Antibody Sales Market Share by Country/Region (2018-2023)
Table 31. Global Synthetic Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Synthetic Antibody Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Synthetic Antibody Sales by Country (2018-2023) & (Units)
Table 34. Americas Synthetic Antibody Sales Market Share by Country (2018-2023)
Table 35. Americas Synthetic Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Synthetic Antibody Revenue Market Share by Country (2018-2023)
Table 37. Americas Synthetic Antibody Sales by Type (2018-2023) & (Units)
Table 38. Americas Synthetic Antibody Sales by Application (2018-2023) & (Units)
Table 39. APAC Synthetic Antibody Sales by Region (2018-2023) & (Units)
Table 40. APAC Synthetic Antibody Sales Market Share by Region (2018-2023)
Table 41. APAC Synthetic Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Synthetic Antibody Revenue Market Share by Region (2018-2023)
Table 43. APAC Synthetic Antibody Sales by Type (2018-2023) & (Units)
Table 44. APAC Synthetic Antibody Sales by Application (2018-2023) & (Units)
Table 45. Europe Synthetic Antibody Sales by Country (2018-2023) & (Units)
Table 46. Europe Synthetic Antibody Sales Market Share by Country (2018-2023)
Table 47. Europe Synthetic Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Synthetic Antibody Revenue Market Share by Country (2018-2023)
Table 49. Europe Synthetic Antibody Sales by Type (2018-2023) & (Units)
Table 50. Europe Synthetic Antibody Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Synthetic Antibody Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Synthetic Antibody Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Synthetic Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Synthetic Antibody Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Synthetic Antibody Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Synthetic Antibody Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Synthetic Antibody
Table 58. Key Market Challenges & Risks of Synthetic Antibody
Table 59. Key Industry Trends of Synthetic Antibody
Table 60. Synthetic Antibody Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Synthetic Antibody Distributors List
Table 63. Synthetic Antibody Customer List
Table 64. Global Synthetic Antibody Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Synthetic Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Synthetic Antibody Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Synthetic Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Synthetic Antibody Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Synthetic Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Synthetic Antibody Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Synthetic Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Synthetic Antibody Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Synthetic Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Synthetic Antibody Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Synthetic Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Synthetic Antibody Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Synthetic Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abcam Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 79. Abcam Synthetic Antibody Product Portfolios and Specifications
Table 80. Abcam Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abcam Main Business
Table 82. Abcam Latest Developments
Table 83. Merck Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Synthetic Antibody Product Portfolios and Specifications
Table 85. Merck Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Cell Signaling Technology Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 89. Cell Signaling Technology Synthetic Antibody Product Portfolios and Specifications
Table 90. Cell Signaling Technology Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Cell Signaling Technology Main Business
Table 92. Cell Signaling Technology Latest Developments
Table 93. GE Healthcare Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 94. GE Healthcare Synthetic Antibody Product Portfolios and Specifications
Table 95. GE Healthcare Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. GE Healthcare Main Business
Table 97. GE Healthcare Latest Developments
Table 98. Thermo Fisher Scientific Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 99. Thermo Fisher Scientific Synthetic Antibody Product Portfolios and Specifications
Table 100. Thermo Fisher Scientific Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Thermo Fisher Scientific Main Business
Table 102. Thermo Fisher Scientific Latest Developments
Table 103. Roche Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Synthetic Antibody Product Portfolios and Specifications
Table 105. Roche Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Santa Cruz Biotechnology Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 109. Santa Cruz Biotechnology Synthetic Antibody Product Portfolios and Specifications
Table 110. Santa Cruz Biotechnology Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Santa Cruz Biotechnology Main Business
Table 112. Santa Cruz Biotechnology Latest Developments
Table 113. Becton Dickinson Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 114. Becton Dickinson Synthetic Antibody Product Portfolios and Specifications
Table 115. Becton Dickinson Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Becton Dickinson Main Business
Table 117. Becton Dickinson Latest Developments
Table 118. Rockland Immunochemicals Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 119. Rockland Immunochemicals Synthetic Antibody Product Portfolios and Specifications
Table 120. Rockland Immunochemicals Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Rockland Immunochemicals Main Business
Table 122. Rockland Immunochemicals Latest Developments
Table 123. Johnson & Johnson Basic Information, Synthetic Antibody Manufacturing Base, Sales Area and Its Competitors
Table 124. Johnson & Johnson Synthetic Antibody Product Portfolios and Specifications
Table 125. Johnson & Johnson Synthetic Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Johnson & Johnson Main Business
Table 127. Johnson & Johnson Latest Developments
List of Figures
Figure 1. Picture of Synthetic Antibody
Figure 2. Synthetic Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Synthetic Antibody Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Synthetic Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Synthetic Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Recombinant Antibodies
Figure 10. Product Picture of Non-Immunoglobulin Derived Synthetic Antibodies
Figure 11. Global Synthetic Antibody Sales Market Share by Type in 2022
Figure 12. Global Synthetic Antibody Revenue Market Share by Type (2018-2023)
Figure 13. Synthetic Antibody Consumed in Cancer
Figure 14. Global Synthetic Antibody Market: Cancer (2018-2023) & (Units)
Figure 15. Synthetic Antibody Consumed in Poisoning
Figure 16. Global Synthetic Antibody Market: Poisoning (2018-2023) & (Units)
Figure 17. Synthetic Antibody Consumed in Viral Infections
Figure 18. Global Synthetic Antibody Market: Viral Infections (2018-2023) & (Units)
Figure 19. Synthetic Antibody Consumed in Septicemia
Figure 20. Global Synthetic Antibody Market: Septicemia (2018-2023) & (Units)
Figure 21. Synthetic Antibody Consumed in Autoimmune Diseases
Figure 22. Global Synthetic Antibody Market: Autoimmune Diseases (2018-2023) & (Units)
Figure 23. Synthetic Antibody Consumed in Others
Figure 24. Global Synthetic Antibody Market: Others (2018-2023) & (Units)
Figure 25. Global Synthetic Antibody Sales Market Share by Application (2022)
Figure 26. Global Synthetic Antibody Revenue Market Share by Application in 2022
Figure 27. Synthetic Antibody Sales Market by Company in 2022 (Units)
Figure 28. Global Synthetic Antibody Sales Market Share by Company in 2022
Figure 29. Synthetic Antibody Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Synthetic Antibody Revenue Market Share by Company in 2022
Figure 31. Global Synthetic Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Synthetic Antibody Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Synthetic Antibody Sales 2018-2023 (Units)
Figure 34. Americas Synthetic Antibody Revenue 2018-2023 ($ Millions)
Figure 35. APAC Synthetic Antibody Sales 2018-2023 (Units)
Figure 36. APAC Synthetic Antibody Revenue 2018-2023 ($ Millions)
Figure 37. Europe Synthetic Antibody Sales 2018-2023 (Units)
Figure 38. Europe Synthetic Antibody Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Synthetic Antibody Sales 2018-2023 (Units)
Figure 40. Middle East & Africa Synthetic Antibody Revenue 2018-2023 ($ Millions)
Figure 41. Americas Synthetic Antibody Sales Market Share by Country in 2022
Figure 42. Americas Synthetic Antibody Revenue Market Share by Country in 2022
Figure 43. Americas Synthetic Antibody Sales Market Share by Type (2018-2023)
Figure 44. Americas Synthetic Antibody Sales Market Share by Application (2018-2023)
Figure 45. United States Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Synthetic Antibody Sales Market Share by Region in 2022
Figure 50. APAC Synthetic Antibody Revenue Market Share by Regions in 2022
Figure 51. APAC Synthetic Antibody Sales Market Share by Type (2018-2023)
Figure 52. APAC Synthetic Antibody Sales Market Share by Application (2018-2023)
Figure 53. China Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Synthetic Antibody Sales Market Share by Country in 2022
Figure 61. Europe Synthetic Antibody Revenue Market Share by Country in 2022
Figure 62. Europe Synthetic Antibody Sales Market Share by Type (2018-2023)
Figure 63. Europe Synthetic Antibody Sales Market Share by Application (2018-2023)
Figure 64. Germany Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Synthetic Antibody Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Synthetic Antibody Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Synthetic Antibody Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Synthetic Antibody Sales Market Share by Application (2018-2023)
Figure 73. Egypt Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Synthetic Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Synthetic Antibody in 2022
Figure 79. Manufacturing Process Analysis of Synthetic Antibody
Figure 80. Industry Chain Structure of Synthetic Antibody
Figure 81. Channels of Distribution
Figure 82. Global Synthetic Antibody Sales Market Forecast by Region (2024-2029)
Figure 83. Global Synthetic Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Synthetic Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Synthetic Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Synthetic Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Synthetic Antibody Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の合成抗体市場予測 2023年-2029年] (コード：LP23DC08691)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の合成抗体市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のPD-1抗体薬市場予測 2023年-2029年
  • 世界の抗ロドプシン抗体市場予測 2023年-2029年
  • 世界のTRPV3モノクローナル抗体市場予測 2023年-2029年
  • 世界のPPP4R1抗体市場予測 2023年-2029年
  • 世界のホスホセリンモノクローナル抗体市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆